NCT03138759View on ClinicalTrials.gov

Effect of Probenecid on Pexidartinib Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

March 30, 2017

Study Completion Date

March 30, 2017

Conditions

Pharmacokinetics in Healthy Volunteers

Interventions

DRUG

Pexidartinib

Orally, on Day 2

DRUG

Probenecid

Orally, on Day 2

Trial Locations (1)

78217

Worldwide Clinical Trials Early Phase Services, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY